Biogen (BIIB)

Biogen (BIIB) Income Statement


Biogen Income Statement

Last quarter (Q3 2023), Biogen's total revenue was $2.53B, an increase of 0.87% from the same quarter last year. In Q3, Biogen's net income was $154.70M. See Biogen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 8.68B$ 7.99B$ 8.85B$ 13.44B$ 14.38B$ 13.45B
Cost of Revenue
$ 2.49B$ 2.28B$ 2.11B$ 1.81B$ 1.96B$ 1.82B
Gross Profit
$ 7.51B$ 7.54B$ 9.76B$ 11.64B$ 12.42B$ 11.64B
Operating Expense
$ 5.53B$ 4.63B$ 5.19B$ 7.19B$ 5.39B$ 5.64B
Operating Income
$ 2.10B$ 2.90B$ 4.57B$ 4.45B$ 7.04B$ 6.00B
Net Non Operating Interest Income Expense
$ 197.40M$ 108.20M$ -278.90M$ -180.50M$ -67.40M$ -88.10M
Other Income Expense
$ -670.80M$ -712.80M$ 1.04B$ 781.70M$ 157.60M$ -13.10M
Pretax Income
$ 1.61B$ 3.59B$ 1.75B$ 5.05B$ 7.13B$ 5.90B
Tax Provision
$ 146.90M$ 632.80M$ 52.50M$ 992.30M$ 1.16B$ 1.43B
Earnings From Equity Interest Net Of Tax
-$ 1.51B$ 34.90M$ 5.30M$ -79.40M$ 0.00
Net Income Common Stockholders
$ 1.68B$ 3.05B$ 1.56B$ 4.00B$ 5.89B$ 4.43B
Basic EPS
$ 10.13$ 20.96$ 10.44$ 24.86$ 31.47$ 21.63
Diluted EPS
$ 10.06$ 20.87$ 10.40$ 24.80$ 31.42$ 21.58
Basic Average Shares
$ 577.70M$ 145.30M$ 149.10M$ 160.90M$ 187.10M$ 204.90M
Diluted Average Shares
$ 580.90M$ 146.00M$ 149.60M$ 161.30M$ 187.40M$ 205.30M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
$ 4.05--$ 33.70$ 33.57$ 26.20
Rent Expense Supplemental
Total Expenses
$ 8.01B$ 6.91B$ 7.30B$ 9.00B$ 7.34B$ 7.45B
Net Income From Continuing And Discontinued Operation
$ 1.46B$ 3.05B$ 1.56B$ 4.00B$ 5.89B$ 4.43B
Normalized Income
$ 946.85M$ 3.38B-$ 3.38B$ 5.72B$ 4.43B
Interest Expense
$ 54.80M--$ 222.50M$ 187.40M$ 200.60M
$ 1.71B$ 3.58B$ 1.72B$ 5.27B$ 7.31B$ 6.10B
$ 2.47B$ 4.09B$ 2.21B$ 5.73B$ 7.80B$ 6.85B
Currency in USD

Biogen Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis